This study identified eight prognostic genes (CETP, CLEC11A, CYP2A6, CYP2A7, GZMB, HGF, LDHC, and PLAU) that significantly contribute to the onset and progression of BC, potentially offering new avenues for therapeutic intervention. This evidence concerns the gene CYP2A6 and breast cancer.